|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 183 of 190 found articles
| Title: |
127TiP Phase II, open-label study to evaluate the safety and efficacy of praluzatamab ravtansine (CX 2009) in metastatic HR-positive/HER2 non-amplified breast cancer (mHR+/HER2− BC) and CX-2009 as monotherapy and in combination with pacmilimab in metastatic triple-negative breast cancer (mTNBC) |
| Author: |
Miller, K.D. Emens, L.A. Tolaney, S.M. Hurvitz, S.A. Hamilton, E. Paton, V. Hannah, A.L. Boni, V. |
| Appeared in: |
Annals of oncology |
| Paging: | Volume 32 () nr. S2 pages S76 |
| Year: |
2021 |
| Contents: | |
| Publisher: |
European Society for Medical Oncology |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 183 of 190 found articles
| << previous | next >> |